Congenital toxoplasmosis: Should we still care about screening?

Food and Waterborne Parasitology - Tập 27 - Trang e00162 - 2022
Eskild Petersen1,2, Valeria Meroni3, Daniel V. Vasconcelos-Santos4, Laurent Mandelbrot5, Francois Peyron6
1Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Denmark
2European Society for Clinical Microbiology and Infectious Diseases, Emerging Infections Task Force, Basel, Switzerland
3Molecular Medicine Department, University of Pavia, Pavia, Italy
4Universidade Federal de Minas Gerais, Faculdade de Medicina, Belo Horizonte, Minas Gerais, Brazil
5Assistance Publique-Hôpitaux de Paris, Service de Gynécologie-Obstétrique, Hôpital Louis Mourier, Colombes, France; Université de Paris; Inserm IAME-U1137, Paris, France; FHU PREMA, Paris, France
6Institut de Parasitologie et de Mycologie Médicale, Hôpital de la Croix Rousse, Lyon, France

Tài liệu tham khảo

Aspöck, 1992, Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria, Scand. J. Infect. Dis., 84, 32 Berrébi, 2010, Long-term outcome of children with congenital toxoplasmosis, Am. J. Obstet. Gynecol., 203, 10.1016/j.ajog.2010.06.002 Binquet, 2019, The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis, PLoS One, 14, 10.1371/journal.pone.0221709 Bobić, 2019, Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings, Food Waterb Parasitol, 16, 10.1016/j.fawpar.2019.e00058 Carneiro, 2013, Genetic characterization of Toxoplasma gondii revealed highly diverse genotypes for isolates from newborns with congenital toxoplasmosis in southeastern Brazil, J. Clin. Microbiol., 51, 901, 10.1128/JCM.02502-12 Chapey, 2017, Evaluation of the LDBIO point of care test for the combined detection of toxoplasmic IgG and IgM, Clin. Chim. Acta, 464, 200, 10.1016/j.cca.2016.10.023 Cortina-Borja, 2010, European multicentre study on congenital toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study, PLoS Med., 7, e1000351, 10.1371/journal.pmed.1000351 Costa, 2013, Real-time PCR as a prognostic tool for human congenital toxoplasmosis, J. Clin. Microbiol., 51, 2766, 10.1128/JCM.00982-13 Couvreur, 1955 Couvreur, 1962, Congenital and maternal toxoplasmosis. A review of 300 cases, Dev. Med. Child. Neurol., 4, 519, 10.1111/j.1469-8749.1962.tb03221.x Desmonts, 1974, Congenital toxoplasmosis: a prospective study of 378 pregnancies, N. Engl. J. Med., 290, 1110, 10.1056/NEJM197405162902003 Desmonts, 1965, Le toxoplasme, la mere et l’enfant, Arch. Franc. Pediatr., 22, 1183 Dunn, 1999, Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling, Lancet, 353, 1829, 10.1016/S0140-6736(98)08220-8 Eichenwald, 1957, Congenital toxoplasmosis: a study of 150 cases, Am. J. Dis. Chld., 94, 411 Feldman, 1953, Congenital toxoplasmosis – a study of 103 cases, Am. J. Dis. Child., 86, 487 Ferguson, 2009, Toxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and Splendore, Mem. Inst. Oswaldo Cruz, 104, 133, 10.1590/S0074-02762009000200003 Foulon, 1999, Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children’s sequelae at age 1 year, Am. J. Obstet. Gynecol., 180, 410, 10.1016/S0002-9378(99)70224-3 Freeman, 2005, And the European multicentre study on congenital toxoplasmosis (EMSCOT). Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children, BMC Pediatr., 5, 10.1186/1471-2431-5-23 Freeman, 2008, Gilbert R and the European multicentre study on congenital toxoplasmosis. Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study, Pediatrics, 121, e1215, 10.1542/peds.2007-2169 Galal, 2019, Diversity of toxoplasma gondii strains at the global level and its determinants, Food Waterborne Parasitol., 15, 10.1016/j.fawpar.2019.e00052 Gilbert, 2003, Gras L for the European multicentre study on congenital toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii, BJOG, 110, 112, 10.1016/S1470-0328(02)02325-X Gilbert, 2002, Congenital toxoplasmosis in the United Kingdom: to screen or not to screen?, J. Med. Screen., 9, 135, 10.1136/jms.9.3.135 Gilbert, 2001, Effect of prenatal treatment on mother to child transmission of toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France, Int. J. Epidemiol., 30, 1303, 10.1093/ije/30.6.1303 Gilbert, 2008, And the European multicentre study on congenital toxoplasmosis (EMSCOT). Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe, PLoS Negl. Trop. Dis., 2, 10.1371/journal.pntd.0000277 Gomez, 2018, Evaluation of three point-of-care tests for detection of toxoplasma immunoglobulin IgG and IgM in the United States: proof of concept and challenges, Open Forum Infect. Dis., 5, 10.1093/ofid/ofy215 Guerina, 1994, Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England regional toxoplasma working group, N. Engl. J. Med., 330, 1858, 10.1056/NEJM199406303302604 Hamidović, 2021, A hotspot of toxoplasma gondii Africa 1 lineage in Benin: how new genotypes from West Africa contribute to understand the parasite genetic diversity worldwide, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0008980 Hirst, 2021, Feasibility and acceptability of community coronavirus disease 2019 testing strategies (FACTS) in a university setting, Open Forum Infect. Dis., 8, 10.1093/ofid/ofab495 Hohlfeld, 1989, Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment, J. Pediatr., 115, 765, 10.1016/S0022-3476(89)80660-2 Holmdahl, 1955, The frequency of congenital toxoplasmosis and some viewpoints on the diagnosis, Acta Paediatr., 44, 322, 10.1111/j.1651-2227.1955.tb04146.x Howe, 1995, Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease, J. Infect. Dis., 172, 1561, 10.1093/infdis/172.6.1561 Janku, 1923, Pathogenesa a patologicka anatomie tak nazvaneho vrozenehonalezem parasitu v sitnici, Cas. Lek. Cesk., 62, 1021 Jones, 2012, Foodborne toxoplasmosis, Clin. Infect. Dis., 55, 845, 10.1093/cid/cis508 Kieffer, 2008, Risk factors for retinochoroiditis during the first 2 years of life in infants with treated congenital toxoplasmosis, Pediatr. Infect. Dis. J., 2008, 27, 10.1097/INF.0b013e318134286d Kijlstra, 2004, Toxoplasma gondii infection in animal-friendly pig production systems, Invest. Ophthalmol. Vis. Sci., 45, 3165, 10.1167/iovs.04-0326 Lebech, 1992, Congenital toxoplasmosis, Scand. J. Infect. Dis., 84, 1, 10.3109/inf.1992.24.suppl-84.01 Logar, 2002, Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women, Scand. J. Infect. Dis., 34, 201, 10.1080/00365540110080386 Mandelbrot, 2020, Congenital toxoplasmosis: what is the evidence for chemoprophylaxis to prevent fetal infection?, Prenat. Diagn., 40, 1693, 10.1002/pd.5758 Mandelbrot, 2018, And the TOXOGEST study group. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial, Am. J. Obstet. Gynecol., 219, 386.e1, 10.1016/j.ajog.2018.05.031 McLeod, 2006, And the toxoplasmosis study group. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, congenital toxoplasmosis study, Clin. Infect. Dis., 42, 1383, 10.1086/501360 Montoya, 2018, Systematic screening and treatment of toxoplasmosis during pregnancy: is the glass half full or half empty?, Am. J. Obstet. Gynecol., 2018, 315, 10.1016/j.ajog.2018.08.001 Olsen, 2020, Seroprevalence of toxoplasma gondii infection in sows and finishers from conventional and organic herds in Denmark: implications for potential future serological surveillance, Prev. Vet. Med., 185, 10.1016/j.prevetmed.2020.105149 Picone, 2020, Toxoplasmosis screening during pregnancy in France: opinion of an expert panel for the CNGOF, J. Gynecol. Obstet. Hum. Reprod., 49, 10.1016/j.jogoh.2020.101814 Prusa, 2015, The Austrian toxoplasmosis register, 1992-2008, Clin. Infect. Dis., 60, e4, 10.1093/cid/ciu724 Prusa, 2017, Congenital toxoplasmosis in Austria: prenatal screening for prevention is cost-saving, PLoS Negl. Trop. Dis., 11, 10.1371/journal.pntd.0005648 Röser, 2010, Congenital toxoplasmosis – a report on the Danish neonatal screening programme 1999–2007, J. Inherit. Metab. Dis., 33, S241, 10.1007/s10545-010-9124-4 Sabin, 1941, Toxoplasmic encephalitis in children, J. Am. Med. Assoc., 116, 801, 10.1001/jama.1941.02820090001001 Sampaio, 2014, Saliva as a source of anti-toxoplasma gondii IgG for enzyme immunoassay in human samples, Clin. Microbiol. Infect., 20, O72, 10.1111/1469-0691.12295 Schmidt, 2006, Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine, Eur. J. Pediatr., 165, 19, 10.1007/s00431-005-1665-4 Shwab, 2014, Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping, Parasitology, 141, 453, 10.1017/S0031182013001844 Stillwaggon, 2011, Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model, PLoS Negl. Trop. Dis., 5, 10.1371/journal.pntd.0001333 SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group, 2007, Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data, Lancet, 369, 115, 10.1016/S0140-6736(07)60072-5 Tan, 2007, And the European multicentre study on congenital toxoplasmosis (EMSCOT). Risk of visual impairment in children with congenital toxoplasmic retinochoroiditis, Am J. Ophthalmol., 144, 648, 10.1016/j.ajo.2007.07.013 Teil, 2016, Treatment of congenital toxoplasmosis: safety of the Sulfadoxine-Pyrimethamine combination in children based on a method of causality assessment, Pediatr. Infect. Dis. J., 35, 634, 10.1097/INF.0000000000001120 Thulliez, 1992, Screening programme for congenital toxoplasmosis in France, Scand. J. Infect. Dis., 84, 43 Valentini, 2015, Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy, J. Perinatol., 35, 90, 10.1038/jp.2014.161 Vasconcelos-Santos, 2009, Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates, Ophthalmology, 116, 2199, 10.1016/j.ophtha.2009.04.042 Wallon, 2013, Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years, Clin. Infect. Dis., 56, 1223, 10.1093/cid/cit032 Welton, 2005, A model of toxoplasmosis incidence in the UK: evidence synthesis and consistency of evidence, J. R. Stat. Soc.: Ser. C: Appl. Stat., 54, 385, 10.1111/j.1467-9876.2005.00490.x